Cancer is Like Cable TV

Article

Cancer is not a single disease, but a collection of many types of the disease.

Incoming American Society of Oncology (ASCO) President George Sledge, MD was quoted at the 2010 annual ASCO meeting saying that "cancer is like cable television. Thirty years ago you had three channels. Now you have 500." It's an interesting--and accurate--analogy. We now know that cancer is not a single disease but rather a collection of many types of the disease. And more importantly, we now know that two people may have the same cancer cell type in the same organ and receive the same treatment, but respond differently. Recent research in genetics and targeted therapies has shown that cancer is a complex disease.

The ASCO meeting, held in Chicago in early June, drew oncologists from around the world to learn about advances in cancer treatment. As more is known about the genetics of cancer, new and refined treatments can be developed. Genetic alterations are linked to the development of a number of cancer types, and once an alteration is identified it may be possible to design a targeted therapy. One of the best examples of this approach is the drug Gleevec® (imatinib mesylate, Novartis, East Hanover, NJ, USA), used to treat patients with Philadelphia chromosome positive chronic myeloid leukemia. Hopefully, additional genetic aberrations will be identified in the near future so that more types of cancer may be cured.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
A panel of 5 experts on iron deficiency anemia
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Phase 2 Data Shows KP1077 Meaningfully Improves Idiopathic Hypersomnia Symptoms
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
© 2024 MJH Life Sciences

All rights reserved.